Context Therapeutics Inc. · NASDAQ:CNTX

Mpm Bioimpact LLC reported a 16.40% stake in Context Therapeutics Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Jan 8, 2025

Mpm Bioimpact LLC reported a 16.40% stake in Context Therapeutics Inc., 14,705,882 shares, as a passive investor on Dec 31, 2024. Filed Jan 8, 2025 (Schedule 13G).

Stake
16.40%
Shares
14,705,882
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
MPM BioImpact LLC16.40%14,705,882

Source

View original at SEC

Related